The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Laikind Paul K since year 2005.
The trader's CIK number is 1292402.
At the time of this reporting, Laikind Paul K is the Chief Executive Offi of Metabasis Therapeutics Inc .
(stock ticker symbol MBRX).
See this page for all insider trading activities at Metabasis Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-11-19||MBRX||Metabasis Therapeutics Inc||Buy||4,700||.63||2,956|
|2008-11-18||MBRX||Metabasis Therapeutics Inc||Buy||1,300||.54||698|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laikind Paul K (Chief Executive Offi of Metabasis Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.